Annual ROE
-45.84%
+3.88%+7.80%
September 1, 2024
Summary
- As of February 7, 2025, CTOR annual return on equity is -45.84%, with the most recent change of +3.88% (+7.80%) on September 1, 2024.
- During the last 3 years, CTOR annual ROE has fallen by -30.86% (-206.01%).
- CTOR annual ROE is now -206.01% below its all-time high of -14.98%, reached on September 1, 2022.
Performance
CTOR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CTOR ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.8% | - |
| 3 y3 years | -206.0% | - |
| 5 y5 years | -206.0% | - |
CTOR ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -206.0% | +7.8% | ||
| 5 y | 5-year | -206.0% | +7.8% | ||
| alltime | all time | -206.0% | +7.8% |
Citius Oncology ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | -45.84%(-7.8%) | - |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | -49.72%(+231.9%) | - |
| Sep 2022 | -14.98% | - |
FAQ
- What is Citius Oncology annual return on equity?
- What is the all time high annual ROE for Citius Oncology?
- What is Citius Oncology annual ROE year-on-year change?
What is Citius Oncology annual return on equity?
The current annual ROE of CTOR is -45.84%
What is the all time high annual ROE for Citius Oncology?
Citius Oncology all-time high annual return on equity is -14.98%
What is Citius Oncology annual ROE year-on-year change?
Over the past year, CTOR annual return on equity has changed by +3.88% (+7.80%)